Erratum: Evidence Why Paroxetine Dose Escalation is Not Effective in Major Depressive Disorder: A Randomized Controlled Trial with Assessment of Serotonin Transporter Occupancy

被引：0
|
作者：
Henricus G Ruhé
Jan Booij
Henk C v Weert
Johannes B Reitsma
Eric JF Fransen
Martin C Michel
Aart H Schene
机构：
来源：
Neuropsychopharmacology | 2009年 / 34卷 / 4期
关键词：
D O I：
10.1038/npp.2008.213
中图分类号：
学科分类号：
摘要：
Correction to: Neuropsychopharmacology advance online publication, 1 October 2008; doi: 10.1038/npp.2008.148 In this article, published online on 1 October 2008, one author's name is spelled incorrectly; it should have appeared as Eric JF Franssen.
引用
收藏
页码：1088 / 1088
相关论文
共 50 条
  • [21] Serotonin transporter occupancy of high dose serotonin Reuptake inhibitor antidepressants in major depressive disorder: An [11C] DASB positron emission tomography (PET) study
    Voineskos, Aristotle
    Sacher, Julia
    Wilson, Alan
    Houle, Sylvain
    Levitan, Robert
    Chopra, Kevin
    Rusjan, Pablo
    Meyer, Jeffrey H.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 107S - 107S
  • [22] A randomized study of escitalopram and paroxetine controlled-release in the treatment of Japanese patients with major depressive disorder
    Kishi, T.
    Kawashima, K.
    Moriwaki, M.
    Otake, Y.
    Mukai, T.
    Matsuda, Y.
    Fujita, K.
    Iwata, N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S338 - S338
  • [23] Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography
    Aristotle N. Voineskos
    Alan A. Wilson
    Anahita Boovariwala
    Sandra Sagrati
    Sylvain Houle
    Pablo Rusjan
    Stephen Sokolov
    Edgar P. Spencer
    Nathalie Ginovart
    Jeffrey H. Meyer
    Psychopharmacology, 2007, 193 : 539 - 545
  • [24] Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C] DASB positron emission tomography
    Voineskos, Aristotle N.
    Wilson, Alan A.
    Boovariwala, Anahita
    Sagrati, Sandra
    Houle, Sylvain
    Rusjan, Pablo
    Sokolov, Stephen
    Spencer, Edgar P.
    Ginovart, Nathalie
    Meyer, Jeffrey H.
    PSYCHOPHARMACOLOGY, 2007, 193 (04) : 539 - 545
  • [25] Randomized controlled trial of repetitive transcranial magnetic stimulation combined with paroxetine for the treatment of patients with first-episode major depressive disorder
    Wang, Yu-Mei
    Li, Ning
    Yang, Lin-Lin
    Song, Mei
    Shi, Le
    Chen, Wen-Hao
    Li, Su-Xia
    Wang, Xue-Yi
    Lu, Lin
    PSYCHIATRY RESEARCH, 2017, 254 : 18 - 23
  • [26] Dose escalation for insufficient response to standard-dose selective serotonin reuptake inhibitors in major depressive disorder -: Systematic review
    Ruhe, Henricus G.
    Huyser, Jochanan
    Swinkels, Jan A.
    Schene, Aart H.
    BRITISH JOURNAL OF PSYCHIATRY, 2006, 189 : 309 - 316
  • [27] Family psychoeducation for major depressive disorder – study protocol for a randomized controlled trial
    Nina Timmerby
    Stephen F. Austin
    Kristian Ussing
    Per Bech
    Claudio Csillag
    Trials, 17
  • [28] Family psychoeducation for major depressive disorder - study protocol for a randomized controlled trial
    Timmerby, Nina
    Austin, Stephen F.
    Ussing, Kristian
    Bech, Per
    Csillag, Claudio
    TRIALS, 2016, 17
  • [29] Electroacupuncture for Residual Insomnia Associated with Major Depressive Disorder: A Randomized Controlled Trial
    Yeung, Wing-Fai
    Chung, Ka-Fai
    Tso, Kwok-Chu
    Zhang, Shi-Ping
    Zhang, Zhang-Jin
    Ho, Lai-Ming
    SLEEP, 2011, 34 (06) : 807 - 815
  • [30] A Randomized Controlled Trial of Intranasal Neuropeptide Y in Patients With Major Depressive Disorder
    Mathe, Aleksander A.
    Michaneck, Miranda
    Berg, Elisabeth
    Charney, Dennis S.
    Murrough, James W.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2020, 23 (12): : 783 - 790
12345